DIA

📢 Call for expression of interest 📢 Are you a manufacturer or medicine developer? Are you an academic working in manufacturing innovation? EMA is calling for case studies on platform technologies for its 4th Listen-and-Learn Focus Group meeting on quality and manufacturing innovation on 19-20 November 2024. ➡️✍️ Submit your case study by 31 July 2024 for a chance to discuss it at the meeting. Key points for discussion will be: 📌 Platforms for medicinal products manufactured using prior knowledge 📌 Platforms for medicinal products against serious health threats like pandemics 📌 Platforms for manufacturing personalised or individualised medicines 🔗 Find out more - https://lnkd.in/djQC9nxj #MedicinesInnovation #QualityInnovation #PlatformTechnologies 

📢AGENDA RELEASED for the Global Clinical Trial Disclosure and Data Transparency Conference! Join us for this essential event where industry leaders and experts will delve into the latest in #clinical #trialdisclosure and #datatransparency. From #regulatory updates to best practices in data sharing, this conference is a must-attend for anyone committed to advancing #transparency in #clinicalresearch. View #CTD24 agenda at: https://ow.ly/GJxN50SCEUW

Join our EU Regulatory Intelligence Training Course and become proficient in navigating the evolving regulatory landscape. This virtual live course, hosted by the EU Regulatory Intelligence Network Group (EU RING), offers hands-on experience and expert insights to boost your regulatory intelligence skills. Gain expertise in: ▪️ Identifying reliable sources of regulatory information ▪️ Assessing the impact of new requirements on business strategies ▪️ Enhancing communication with internal stakeholders Secure your spot today and benefit from the early bird discount before it's gone: https://bit.ly/3Lp4xsY. Doerte Braumann Bertrand G. Fournier kasia nowok Iain T. #RegulatoryIntelligence #RegulatoryAffairs #DIA #Learning

Explore exciting opportunities to showcase your brand and services to the perfect audience in the life science industry through the DIA Exhibitor and Sponsor Newsletter. Don't miss out - click the link to learn more! https://lnkd.in/eKzXJ_3g #branding #marketing #lifescience"

Join us at the DIA India Annual Meeting 2024, where key stakeholders will converge to explore the future of healthcare in India. This year, we are diving into three specialized tracks — Pharmacovigilance, Clinical and Regulatory, and Medical Devices — all to elevate patient safety. The early bird rates are ending in less than a month. Follow our event page for the latest updates and details. Prof. Moin Don Dr. Ashish Indani Fahd Khan Prashant Joshi Ritu Jaswal Dr Shadab Makhdoomi Dr.Sonica Sachdeva Batra Dr Vijay Venkatraman Janarthanan Vijay Bhargav Swapnali Raut Pramod Kashid manjusha rajarshi Manish Paliwal omprakash sadhwani Priyadarshini Arambam Susan Korah Nathalie Preiswerk Dr Ashok Swain Nishank Nivedit #DIAIndia #Pharmacovigilance #Clinical #RegulatoryAffairs #MedicalDevices

The July issue of our #GlobalForum is now live! This month, we're diving into groundbreaking topics shaping the future of #global healthcare and #clinical trials with articles like these: 💡#ClinicalTrials in Wartime: One Patient’s Journey to Survival 💡Implementing #Patient-Reported Outcomes in #Cancer Clinical Trials 💡How to Communicate Unapproved Uses Without Breaking the Law Stay informed. Stay connected. Together, we're advancing the field! https://ow.ly/PCqT50SzUKw #HealthcareInnovation #DataTransparency #GlobalHealth

The EU regulatory landscape for medicine development is complex, but our session from DIA Europe 2024 on ‘Complexity: Interplay and Interface of Different Legislations’ can help! This session explores the challenges and opportunities that arise when various regulations intersect in the development and manufacturing of medicines. Join a diverse panel of experts including medicine developers, policymakers, regulators, patients, and academics as they discuss: ◾ The impact of overlapping regulations in R&D and manufacturing. ◾ Practical strategies to navigate these complexities. ◾ Guiding principles for effective policy development. Don't miss this valuable resource! Watch the session now and gain insights to navigate the evolving regulatory environment: https://bit.ly/46iCK7n. For more information and to stay updated on DIA Europe 2025, visit our website: https://bit.ly/3LmbH19. #DIAEurope #HealthcarePolicy #Learning #RegulatoryAffairs

{𝐍𝐞𝐰 𝐞𝐁𝐨𝐨𝐤 𝐉𝐮𝐬𝐭 𝐑𝐞𝐥𝐞𝐚𝐬𝐞𝐝!} 𝐀𝐜𝐡𝐢𝐞𝐯𝐢𝐧𝐠 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞 𝐢𝐧 #𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 Get our eBook and learn valuable insights for #RegulatoryDrug teams: Best Practices in #RIM Capabilities and Functional Interfaces: https://ow.ly/e5mX50SzRO7

Don't miss BioSpace's Lori Ellis (Katz) in her incredible interview with FDA's Dr. Peter Marks!

Ready to increase your expertise in risk management plans? Join our exclusive live-virtual training course this September and explore the essential aspects of creating an EU Risk Management Plan (EU-RMP). Here’s what you will gain: ◾ Hands-on experience in project management, medical writing, and maintenance of EU-RMPs. ◾ A thorough understanding of GVP Module V (Rev. 2) and its impact on Marketing Authorisation Holders. ◾ An advanced preview of the upcoming changes in the GVP Rev 3 and RMP Template Rev 3, with a special emphasis on ATMPs. Don't miss out on this great opportunity to increase your expertise on RMPs with our expert instructors! Register by 30 July for the early bird rate: https://bit.ly/4bDrOlF. #RMP24 #Pharmacovigilance #DrugSafety #RMP #GVP